KIORA PHARMACEUTICALS INC (KPHMW)
2024-06-30 | ||||
|---|---|---|---|---|
| Total revenue | 20 | |||
| Research and development | 906.68 | |||
| General and administrative | 1,537.973 | |||
| Change in fair value of contingent consideration | 120.234 | |||
| Total operating expenses | 2,564.887 | |||
| Operating income (loss) | -2,544.887 | |||
| Other income, net | -18.861 | |||
| Interest income, net | 342.102 | |||
| Total other income, net | 323.241 | |||
| Net income (loss) | -2,221.646 | |||
| Unrealized loss on marketable securities | -2.828 | |||
| Foreign currency translation adjustments | 21.467 | |||
| Comprehensive income (loss) | -2,203.007 | |||
| Basic eps | -0.53 | |||
| Diluted eps | -0.53 | |||
| Basic average shares | 4,170,627 | |||
| Diluted average shares | 4,170,627 | |||